Health · Medical Research · 4 hrs ago

Sutter Health opens registry to study lesser-known form of dementia

Sutter Health opens registry to study lesser-known form of dementia

Sutter Health has launched a registry to study LATE, a form of dementia that can look like Alzheimer's disease.

LATE is linked to a buildup of the TDP-43 protein in brain areas involved in memory, rather than the amyloid and tau associated with Alzheimer's.

There are currently no specific biomarkers or known treatments for LATE, making it difficult to identify and treat.

Autopsy studies suggest LATE pathology is present in about 40% of people aged 80 and older, though it may be the main cause of cognitive decline or occur alongside other conditions.

The registry collects blood, spinal fluid and clinical information from patients who meet criteria for suspected LATE across participating Sutter Health locations in California.

At the time researchers submitted their conference abstract, they had identified 21 eligible patients, and six had agreed to take part.

Researchers aim to develop biomarkers and prepare for future treatment trials as the registry grows.

1 source

Related

What people are saying

Shawn KileChair of Sutter Health's Advanced Neuroscience Service Line
Based on autopsy studies, we are learning that LATE pathology is showing up in approximately 40% of people age 80 and older. This is significant.
via News-Medical
By collecting blood and cerebrospinal fluid from clinically suspected cases over time, this biobank registry can help us close current knowledge gaps and, ultimately, move toward a biomarker-driven diagnosis and more precise treatments for LATE.
via News-Medical
Armen MoughamianChief of memory for Sutter's Neuroscience Service Line and medical director of Sutter's Ray Dolby Brain Health Center at California Pacific Medical Center
A health system like Sutter can leverage their patients to advance dementia research, from identifying patients in clinical care and collecting samples over time to studying new biomarkers and preparing for future trials.
via News-Medical
Greg TranahSenior scientist and director, Sutter Biobank
The LATE registry demonstrates the broader promise of the Sutter Biobank: connecting biological samples with rich clinical information from patients receiving care across our system.
via News-Medical